Immutep Ltd. Files Routine 6-K Report
Ticker: PRRUF · Form: 6-K · Filed: Dec 12, 2024 · CIK: 1506184
| Field | Detail |
|---|---|
| Company | Immutep Ltd (PRRUF) |
| Form Type | 6-K |
| Filed Date | Dec 12, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, compliance
TL;DR
IMMUTEP files routine 6-K, no major news, just compliance.
AI Summary
Immutep Ltd. filed a Form 6-K on December 12, 2024, reporting as a foreign private issuer. The company, formerly known as Prima BioMed Ltd, is incorporated in Australia and has its principal executive offices in Sydney. This filing is routine and does not contain specific financial or operational updates beyond its status as a periodic report.
Why It Matters
This filing confirms Immutep Ltd.'s compliance with SEC reporting requirements for foreign private issuers, providing transparency to investors about its regulatory status.
Risk Assessment
Risk Level: low — This is a standard SEC filing for a foreign private issuer and does not contain new material information that would inherently increase risk.
Key Players & Entities
- IMMUTEP Ltd (company) — Registrant
- Prima BioMed Ltd (company) — Former company name
- December 12, 2024 (date) — Filing date
- 001-35428 (other) — Commission File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer has made or is required to make public pursuant to the laws of its home country or has filed or is required to file with a stock exchange on which its securities are traded.
When was this Form 6-K filed?
This Form 6-K was filed on December 12, 2024.
What is the Commission File Number for IMMUTEP Ltd?
The Commission File Number for IMMUTEP Ltd is 001-35428.
What was IMMUTEP Ltd's former company name?
IMMUTEP Ltd's former company name was Prima BioMed Ltd.
Where are IMMUTEP Ltd's principal executive offices located?
IMMUTEP Ltd's principal executive offices are located at Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.
Filing Stats: 261 words · 1 min read · ~1 pages · Grade level 17.2 · Accepted 2024-12-12 15:33:26
Filing Documents
- d891896d6k.htm (6-K) — 9KB
- d891896dex991.htm (EX-99.1) — 18KB
- g891896g30z01.jpg (GRAPHIC) — 7KB
- 0001193125-24-276918.txt ( ) — 38KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: December 12, 2024 IMMUTEP LIMITED By: /s/ Marc Voigt Name: Marc Voigt Title: Chief Executive Officer